Literature DB >> 11283912

Wet extrusion of fibronectin-fibrinogen cables for application in tissue engineering.

S Underwood1, A Afoke, R A Brown, A J MacLeod, P A Shamlou, P Dunnill.   

Abstract

A method for the wet extrusion of human plasma-derived fibronectin-fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without sodium alginate and carboxymethylcellulose (CMC) are tested. The rheological properties of the protein solutions changed from Newtonian to shear thinning non-Newtonian in the presence of small quantities of these additives, the apparent viscosity increased, and the extrusion properties of the protein solutions improved. Cables were prepared using a capillary with a diameter of 1 mm and overall length of 18 mm. Cable diameter was reduced to about 0.5 mm by drawing using a series of rollers. Cables prepared with sodium alginate were found to have suitable properties, and those made with CMC were sticky and difficult to handle. Solutions containing no sodium alginate required a minimum total protein concentration of about 70 mg/mL for extrusion. Extruded cables were prepared with solutions containing 140 mg/mL total protein with 12.9 mg/mL alginate (high protein), and 46 mg/mL total protein with 47.6 mg/mL of sodium alginate (high alginate). The mechanical strength of the extruded cables was within the range suitable for application in tissue engineering. Extrusion of the protein solutions into cables was achieved in a coagulation bath. Cables with a mechanical strength of approximately 30 N/mm(2), suitable for wound repair and nerve regeneration applications, were prepared with a coagulation bath containing 0.25 M HCl, 2% CaCl(2) at a pH of <0.9. These cables also had a large average elongation at break of 52%, and showed an increase in cable length after breakage (permanent set) of 20%, demonstrating the potential for drawing the cables down to a fine diameter. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283912     DOI: 10.1002/bit.1062

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  7 in total

1.  Heterogeneous differentiation of human mesenchymal stem cells in response to extended culture in extracellular matrices.

Authors:  Jose A Santiago; Ryan Pogemiller; Brenda M Ogle
Journal:  Tissue Eng Part A       Date:  2009-12       Impact factor: 3.845

2.  The in vitro analysis of migration and polarity of blastema cells in the extracellular matrix derived from bovine mesenteric in the presence of fibronectin.

Authors:  Kamelia Kohannezhad; Soroush Norouzi; Maryam Tafazoli; Safoura Soleymani; Nasser Mahdavi Shahri; Amin Tavassoli
Journal:  Anat Cell Biol       Date:  2022-06-07

3.  Collagen-Fibrinogen Lyophilised Scaffolds for Soft Tissue Regeneration.

Authors:  Jennifer Shepherd; Daniel Bax; Serena Best; Ruth Cameron
Journal:  Materials (Basel)       Date:  2017-05-23       Impact factor: 3.623

Review 4.  Recent Advances in Biopolymeric Composite Materials for Tissue Engineering and Regenerative Medicines: A Review.

Authors:  Muhammad Umar Aslam Khan; Saiful Izwan Abd Razak; Wafa Shamsan Al Arjan; Samina Nazir; T Joseph Sahaya Anand; Hassan Mehboob; Rashid Amin
Journal:  Molecules       Date:  2021-01-25       Impact factor: 4.411

Review 5.  A Minireview of Microfluidic Scaffold Materials in Tissue Engineering.

Authors:  Anh Tong; Roman Voronov
Journal:  Front Mol Biosci       Date:  2022-01-11

6.  Self-assembled fibrinogen-fibronectin hybrid protein nanofibers with medium-sensitive stability.

Authors:  Karl Scheuer; Christian Helbing; Izabela Firkowska-Boden; Klaus D Jandt
Journal:  RSC Adv       Date:  2021-04-16       Impact factor: 3.361

7.  Development of Electrospun Chitosan-Polyethylene Oxide/Fibrinogen Biocomposite for Potential Wound Healing Applications.

Authors:  Tony T Yuan; Ann Marie DiGeorge Foushee; Monica C Johnson; Angela R Jockheck-Clark; Jonathan M Stahl
Journal:  Nanoscale Res Lett       Date:  2018-04-02       Impact factor: 4.703

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.